417 related articles for article (PubMed ID: 33038418)
1. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
Yarmohammadi A; Yarmohammadi M; Fakhri S; Khan H
Eur J Pharmacol; 2021 Jan; 890():173620. PubMed ID: 33038418
[TBL] [Abstract][Full Text] [Related]
2. JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy.
Satarker S; Tom AA; Shaji RA; Alosious A; Luvis M; Nampoothiri M
Postgrad Med; 2021 Jun; 133(5):489-507. PubMed ID: 33245005
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.
Elizagaray ML; Mazitelli I; Pontoriero A; Baumeister E; Docena G; Raimondi C; Correger E; Rumbo M
Biomed J; 2023 Feb; 46(1):81-92. PubMed ID: 35948250
[TBL] [Abstract][Full Text] [Related]
4. The Many Faces of JAKs and STATs Within the COVID-19 Storm.
Grant AH; Estrada A; Ayala-Marin YM; Alvidrez-Camacho AY; Rodriguez G; Robles-Escajeda E; Cadena-Medina DA; Rodriguez AC; Kirken RA
Front Immunol; 2021; 12():690477. PubMed ID: 34326843
[TBL] [Abstract][Full Text] [Related]
5. Compassionate use of ruxolitinib in patients with SARS-Cov-2 infection not on mechanical ventilation: Short-term effects on inflammation and ventilation.
Mortara A; Mazzetti S; Margonato D; Delfino P; Bersano C; Catagnano F; Lauriola M; Grosso P; Perseghin G; Ippoliti G
Clin Transl Sci; 2021 May; 14(3):1062-1068. PubMed ID: 33403775
[TBL] [Abstract][Full Text] [Related]
6. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection.
Jung HE; Lee HK
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834939
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
Dzobo K; Chiririwa H; Dandara C; Dzobo W
OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
[TBL] [Abstract][Full Text] [Related]
8. Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches.
Choi H; Shin EC
BMB Rep; 2022 Jan; 55(1):11-19. PubMed ID: 34903319
[TBL] [Abstract][Full Text] [Related]
9. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
11. Covid-19 and development of heart failure: mystery and truth.
Onohuean H; Al-Kuraishy HM; Al-Gareeb AI; Qusti S; Alshammari EM; Batiha GE
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2013-2021. PubMed ID: 34480616
[TBL] [Abstract][Full Text] [Related]
12. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
13. Statins: Beneficial Effects in Treatment of COVID-19.
Lashgari NA; Roudsari NM; Shamsnia H; Shayan M; Momtaz S; Abdolghaffari AH; Matbou Riahi M; Jamialahmadi T; Guest PC; Reiner Ž; Sahebkar A
Adv Exp Med Biol; 2023; 1412():457-476. PubMed ID: 37378783
[TBL] [Abstract][Full Text] [Related]
14. JAK inhibition as a new treatment strategy for patients with COVID-19.
Huang J; Zhou C; Deng J; Zhou J
Biochem Pharmacol; 2022 Aug; 202():115162. PubMed ID: 35787993
[TBL] [Abstract][Full Text] [Related]
15. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.
Bertoni A; Penco F; Mollica H; Bocca P; Prigione I; Corcione A; Cangelosi D; Schena F; Del Zotto G; Amaro A; Paladino N; Pontali E; Feasi M; Signa S; Bustaffa M; Caorsi R; Palmeri S; Contini P; De Palma R; Pfeffer U; Uva P; Rubartelli A; Gattorno M; Volpi S
J Allergy Clin Immunol; 2022 Oct; 150(4):796-805. PubMed ID: 35835255
[TBL] [Abstract][Full Text] [Related]
17. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
Front Immunol; 2022; 13():888897. PubMed ID: 35663932
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19.
Khokhar M; Tomo S; Purohit P
Meta Gene; 2022 Feb; 31():100990. PubMed ID: 34722158
[TBL] [Abstract][Full Text] [Related]
20. Role of Toll-like receptors in the pathogenesis of COVID-19.
Khanmohammadi S; Rezaei N
J Med Virol; 2021 May; 93(5):2735-2739. PubMed ID: 33506952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]